Immunotherapy, which is currently one of the hottest fields of cancer research, is built on precision medicine. Immunotherapy is a novel technique of identifying and controlling diseases such as cancer by harnessing the potential of our immune systems. Immunotherapy is being researched in almost all types of cancer. Precision immunotherapy aims to address the essential issue of tumor-specific targeting, ensuring that the immune system's efficacy is aimed solely at cancer cells with little collateral damage to healthy cells. Precision immunotherapy's aspirational goal is to be able to properly forecast a patient's best response to highly tailored, personalized immunotherapies guided by biomarkers, such as phenotypic, genotypic, proteomic, cellular, or metabolic biomarkers.
Precision psychiatry is a new discipline within precision medicine that strives to discover and harness individual differences in biology, lifestyle, environment, and social determinants of health to enhance mental health prevention, diagnosis, and treatment. Neuropsychiatric diseases are becoming recognized as affecting people from all walks of life and causing a huge amount of pain, impairment, and even death. The next stage in realizing the potential of precision psychiatry is to include techniques from machine learning guided trials for tailored therapies, resulting in a new generation of findings in psychiatry that goes beyond existing group-based approaches.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States